Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid

Randomized Comparative Study on Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparison Between Tacrolimus + MMF and Tacrolimus + Steroid

The aim of this study is to compare immunosuppression protocol of tacrolimus + MMF with that of tacrolimus + steroid for preventing recurrence of hepatitis C after living donor liver transplantation.

Inclusion Criteria:

• Recipient of living donor liver transplantation for HCV-related cirrhosis

Exclusion Criteria:

• ABO blood type incompatible transplant case
• Renal dysfunction (serum creatinine >2.0 mg/dL)
• WBC < 1,000/mm3
• Hemoglobin < 8 g/dL
• Platelet <30,000 /mm3